Flavones, including baicalin, baicalein, and wogonin, are the major bioactive polyphenolic compounds accumulated in the roots of Scutellaria baicalensis and are well known for their diverse pharmacological properties, including antioxidant, anti-inflammatory, antimicrobial, antiviral, and anticancer activities. Increasing the production of these valuable flavones has become an important objective in the metabolic engineering of this medicinal plant. In the present study, we investigated the regulatory role of the Arabidopsis thaliana MYB12 (AtMYB12) transcription factor in flavone biosynthesis using S. baicalensis hairy root cultures. Overexpression of AtMYB12 significantly enhanced the transcript levels of several key flavone biosynthetic genes, including SbPAL3, SbCHS2, SbCHI, SbFNSII-2, and SbCYP82D1.1, thereby promoting metabolic flux toward flavone biosynthesis. As a result, the engineered hairy roots accumulated baicalin, baicalein, and wogonin at levels of 45.12 ± 4.54, 10.44 ± 0.64, and 6.19 ± 0.59 mg/g dry weight, respectively. These concentrations represented increases of 247%, 617%, and 206%, respectively, compared with those in wild-type hairy roots used as the control. The coordinated upregulation of multiple biosynthetic genes suggests that AtMYB12 functions as a positive regulator of flavone biosynthesis in S. baicalensis. Collectively, these findings demonstrate that AtMYB12-mediated metabolic engineering is an effective strategy for enhancing flavone production and provides a promising platform for the sustainable, large-scale production of high-value medicinal flavones for pharmaceutical and nutraceutical applications.